SUPERNUS PHARMACEUTICALS
SUPN·868459108·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
SUPN (SUPERNUS PHARMACEUTICALS) is held by 153 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($434.9M), MILLENNIUM MANAGEMENT LLC ($179.2M), VANGUARD PORTFOLIO MANAGEMENT LLC ($153.7M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 78 funds bought SUPN.
Who's Trading
Source dates: Price Sep 21, 2026 · Insiders Aug 14, 2026 · Activists Aug 6, 2026 · Congress Apr 7, 2026
Top Holders
Showing 1-20 of 171
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer